Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-124375
Filing Date
2023-04-28
Accepted
2023-04-28 08:01:00
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d483588d10ka.htm   iXBRL 10-K/A 421644
2 EX-31.3 d483588dex313.htm EX-31.3 3927
3 EX-31.4 d483588dex314.htm EX-31.4 3901
  Complete submission text file 0001193125-23-124375.txt   678055

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alrn-20221231.xsd EX-101.SCH 4976
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20221231_cal.xml EX-101.CAL 675
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20221231_def.xml EX-101.DEF 1680
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20221231_lab.xml EX-101.LAB 22052
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20221231_pre.xml EX-101.PRE 17164
10 EXTRACTED XBRL INSTANCE DOCUMENT d483588d10ka_htm.xml XML 9450
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38130 | Film No.: 23860263
SIC: 2834 Pharmaceutical Preparations